Drug Profile
Daltroban
Alternative Names: BM 13505; SKF 96148Latest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator Roche
- Developer GSK; Roche
- Class Anti-ischaemics; Antiplatelets; Immunotherapies; Phenylacetates; Small molecules; Sulfonamides; Vascular disorder therapies
- Mechanism of Action Platelet aggregation inhibitors; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ischaemic heart disorders; Thrombosis
Most Recent Events
- 06 Oct 1997 Discontinued-III for Ischaemic heart disorders (PO)
- 06 Oct 1997 Discontinued-III for Thrombosis in Germany (PO)
- 06 Oct 1997 Discontinued-III for Thrombosis in United Kingdom (PO)